Organon CFO exercises 15,071 RSUs, covers taxes
Organon & Co. Chief Financial Officer Matthew M. Walsh exercised restricted stock units into common shares and had some shares withheld for taxes.
Rhea-AI Filing Summary
Organon & Co. Chief Financial Officer Matthew M. Walsh exercised restricted stock units into common shares and had some shares withheld for taxes. On March 29, 2026, 15,071 restricted stock units converted into 15,071 shares of Organon common stock at a stated price of $0.00 per share.
To cover tax obligations, 5,162 of these common shares were withheld at a price of $5.84 per share. After these compensation-related transactions, Walsh directly owned 190,660 shares of Organon common stock. The underlying restricted stock units vest in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
15,071 shares exercised/converted
Exercise
3 txns
Insider
WALSH MATTHEW M
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 15,071 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,071 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 5,162 | $5.84 | $30K |
Holdings After Transaction:
Restricted Stock Units — 15,071 contracts (Direct);
Common Stock — 190,660 shares (Direct)
Footnotes (3)
- F1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- F2. Each RSU represents a contingent right to receive one share of Organon common stock.
- F3. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Key Figures
RSUs exercised: 15,071 units
Shares received: 15,071 shares
Tax withholding shares: 5,162 shares
+3 more
6 metrics
RSUs exercised
15,071 units
Restricted Stock Units converted to common stock on March 29, 2026
Shares received
15,071 shares
Organon common stock issued from RSU conversion
Tax withholding shares
5,162 shares
Common shares withheld to satisfy tax obligations
Tax withholding price
$5.84 per share
Closing market price on March 27, 2026 used for withholding
Post-transaction holdings
190,660 shares
Organon common stock directly owned after transactions
RSU vesting schedule
3 equal installments
Vesting on March 29, 2025, 2026, and 2027
Key Terms
Restricted Stock Units, RSU, Exercise or conversion of derivative security, tax-withholding disposition, +1 more
5 terms
Restricted Stock Units financial
"This price is the closing market price of Organon & Co. common stock ... under which the Restricted Stock Units ("RSU") were awarded."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
tax-withholding disposition financial
"transaction_action: tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
contingent right financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
FAQ
What insider transaction did Organon (OGN) report for CFO Matthew Walsh?
Organon reported that CFO Matthew M. Walsh exercised 15,071 restricted stock units into 15,071 shares of common stock. The transaction is compensation-related and reflects the vesting and settlement of previously granted equity awards rather than an open-market stock purchase.
Was the Organon (OGN) CFO’s Form 4 transaction an open-market stock sale or purchase?
No. The filing shows an exercise or conversion of restricted stock units and a tax-withholding disposition. Shares were withheld at $5.84 per share to satisfy tax obligations, so this was not an open-market buy or sell decision in the usual trading sense.
What are Restricted Stock Units (RSUs) in the context of Organon (OGN)?
Restricted Stock Units are equity awards that give the holder a contingent right to receive shares. In this case, each RSU represents one share of Organon common stock, vesting and distributing in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
